MIAMI, April 03, 2018 -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced that is has released its investor presentation for public view.
The Company has uploaded its investor presentation and accompanying video on its website at:
https://progressivecareus.com/investor-presentation-march-2018/
The presentation contains a brief overview of the company, its operations, 2017 results, and agenda for the coming year.
“We feel it is important to our shareholders and the investing public to see me deliver our Company’s story,” stated S. Parikh Mars, CEO. “We hope to build upon this opportunity by developing a forum for more direct access to the Company and more content curated and produced by me personally. We think this level of transparency will build confidence in the market and provide an outlet for us to begin leading the conversation on a variety of topics in business and healthcare.”
Get connected and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact Armen Karapetyan Senior Advisor Business Development [email protected] www.progressivecareus.com www.pharmcopharmacy.com


SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Apple Restores Telegram to App Store After Content Policy Violation
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 



